Use este identificador para citar ou linkar para este item: http://repositorio.ufla.br/jspui/handle/1/42936
Título : COVID-19: pathophysiology, treatment options, nanotechnology approaches, and research agenda to combating the SARS-CoV2 pandemic
Autor: Bhavana, Valamla
Thakor, Pradip
Singh, Shashi Bala
Mehra, Neelesh Kumar
Palavras-chave: COVID-19
Nanotechnology
Research agenda
Post COVID-19
Publicador: Elsevier
Data da publicação: Nov-2020
Referência: BHAVANA, V. et al. COVID-19: pathophysiology, treatment options, nanotechnology approaches, and research agenda to combating the SARS-CoV2 pandemic. Life Sciences, [S.l.], v. 261, Nov. 2020.
Abstract: The recent corona virus disease (COVID-19) outbreak has claimed the lives of many around the world and highlighted an urgent need for experimental strategies to prevent, treat and eradicate the virus. COVID-19, an infectious disease caused by a novel corona virus and no approved specific treatment is available yet. A vast number of promising antiviral treatments involving nanotechnology are currently under investigation to aid in the development of COVID-19 drug delivery. The prospective treatment options integrating the ever-expanding field of nanotechnology have been compiled, with the objective to show that these can be potentially developed for COVID-19 treatment. This review summarized the current state of knowledge, research priorities regarding the pandemic and post COVID-19. We also focus on the possible nanotechnology approaches that have proven to be successful against other viruses and the research agenda to combat COVID-19.
URI: https://www.sciencedirect.com/science/article/pii/S0024320520310882
http://repositorio.ufla.br/jspui/handle/1/42936
Idioma: en_US
Aparece nas coleções:FCS - Artigos sobre Coronavirus Disease 2019 (COVID-19)

Arquivos associados a este item:
Não existem arquivos associados a este item.


Os itens no repositório estão protegidos por copyright, com todos os direitos reservados, salvo quando é indicado o contrário.